The Department of Justice said it will not challenge collaborative efforts by the five of the biggest U.S. medical distributors to source and distribute medical personal protective equipment. But what remains to be seen—and what regulators will have to consider—is whether concentrated markets will learn to coordinate more easily after the crisis has passed.

Goldman Sachs Group Inc. lost its bid to undo class certification in a suit accusing it of misleading investors about conflicts of interests surrounding certain collateralized debt obligation transactions, the Second Circuit said Tuesday.

Kaiser Foundation Health Plan Inc. doesn’t have to cover a $68,825 bill for a teenager’s four-month stay at a wilderness therapy facility, the Ninth Circuit ruled.

Funders, lawyers, and watchers of the litigation finance industry are seeing various indications of a growing industry. While the coronavirus pandemic will undoubtedly change the legal profession and surrounding industries, there seems to be consensus that litigation finance is fairly well inoculated against the looming economic downturn.

As the market for biotech and other medical companies developing vaccines, medicines and medical instruments continues to grow, Goodwin Procter is launching a PropSci practice to handle the industry’s specialized real estate needs.

With more attorneys seeking online reviews to build their practices, and also itching to be able to respond to bad ones, some state bars have issued or are considering ethics opinions that give lawyers some leeway—if not much.